Skip to main content

Table 2 Semiquantitative values for PSMA uptake and mpMRI

From: Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients

Semiquantitative parameters

Total

EPD + 

EPD−

p-value

SUVmax(mean ± SD)

14.2 ± 10

16.7 ± 10.4

12.4 ± 9.2

0.081

PSMAvol(mean ± SD)

6.7 ± 8.4

10.4 ± 10.7

3.9 ± 4.2

0.004

PSMAtot(mean ± SD)

53.2 ± 82.5

86.7 ± 109.5

28.4 ± 37.1

0.008

ADCmin(mean ± SD)

0.534* ± 0.252

0.525** ± 0.209

0.539 ± 0.276

0.818

ADCmean(mean ± SD)

0.942* ± 0.232

0.922** ± .218

0.956 ± 0.238

0.546

mpMRI LCC (mean ± SD)

20.4 ± 16.5

26.6 ± 18.9

15.8 ± 12.6

0.009

mpMRI volume (mean ± SD)

3.0 ± 6.0

4.3 ± 8

2.1 ± 3.6

0.162

  1. Statistically significant p-values are marked by bold font
  2. EPD extraprostatic disease, SUV standardized uptake value, max maximum, min minimum, SD standard deviation, ADC apparent diffusion coefficient, LCC longest capsular contact
  3. *72/73 patients assessable
  4. **30/31 patients assessable